MOSHKEVICH SOLOMON (PRESIDENT, CLINICALDIAGNOSTICS) sold 2.6% of their position (3.41K shares) of NATERA, INC. on the open market
Open‑market sale worth $905.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−410.00
Price / share
$267.99
Trade value
$109.88K
% of position
Common Stock
Shares
−300.00
Price / share
$259.98
Trade value
$77.99K
% of position
Common Stock
Shares
−200.00
Price / share
$261.49
Trade value
$52.30K
% of position
Common Stock
Shares
−947.00
Price / share
$263.94
Trade value
$249.95K
% of position
Common Stock
Shares
−192.00
Price / share
$265.27
Trade value
$50.93K
% of position
Common Stock
Shares
−1.23K
Price / share
$267.79
Trade value
$330.18K
% of position
Common Stock
Shares
−128.00
Price / share
$268.70
Trade value
$34.39K
% of position
Net shares
−3.41K
Net value
-$905.63K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/3/2026 | S · Sale | −410.00 | $267.99 | $109.88K | 0.3% | 132.43K | 132.02K |
| Common Stock Direct | 8/3/2026 | S · Sale | −300.00 | $259.98 | $77.99K | 0.2% | 132.02K | 131.72K |
| Common Stock Direct | 8/3/2026 | S · Sale | −200.00 | $261.49 | $52.30K | 0.2% | 131.72K | 131.52K |
| Common Stock Direct | 8/3/2026 | S · Sale | −947.00 | $263.94 | $249.95K | 0.7% | 131.52K | 130.57K |
| Common Stock Direct | 8/3/2026 | S · Sale | −192.00 | $265.27 | $50.93K | 0.1% | 130.57K | 130.38K |
| Common Stock Direct | 8/3/2026 | S · Sale | −1.23K | $267.79 | $330.18K | 0.9% | 130.38K | 129.15K |
| Common Stock Direct | 8/3/2026 | S · Sale | −128.00 | $268.70 | $34.39K | 0.1% | 129.15K | 129.02K |
| Total | −3.41K | -$905.63K | ||||||